These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 33116498)

  • 21. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
    Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
    Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatic multifunctional biodegradable polymers for pH- and ROS-responsive anticancer drug delivery.
    Su M; Xiao S; Shu M; Lu Y; Zeng Q; Xie J; Jiang Z; Liu J
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111067. PubMed ID: 32388121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced antitumor efficacy of folate targeted nanoparticles co-loaded with docetaxel and curcumin.
    Hu L; Pang S; Hu Q; Gu D; Kong D; Xiong X; Su J
    Biomed Pharmacother; 2015 Oct; 75():26-32. PubMed ID: 26463628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutathione conjugated polyethylenimine on the surface of Fe
    Aeineh N; Salehi F; Akrami M; Nemati F; Alipour M; Ghorbani M; Nikfar B; Salehian F; Riyahi Alam N; Sadat Ebrahimi SE; Foroumadi A; Khoobi M; Rouini M; Dibaei M; Haririan I; Ganjali MR; Safaei S
    J Biomater Sci Polym Ed; 2018 Jul; 29(10):1109-1125. PubMed ID: 29320951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery.
    Su M; Xie J; Zeng Q; Shu M; Liu J; Jiang Z
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111125. PubMed ID: 32600724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional pH-Responsive Folate Receptor Mediated Polymer Nanoparticles for Drug Delivery.
    Cai X; Yang X; Wang F; Zhang C; Sun D; Zhai G
    J Biomed Nanotechnol; 2016 Jul; 12(7):1453-62. PubMed ID: 29337470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors.
    Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G
    J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
    Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo.
    Yang DH; Kim HJ; Park K; Kim JK; Chun HJ
    Drug Deliv; 2018 Nov; 25(1):950-960. PubMed ID: 29658319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier.
    Li H; Li M; Chen C; Fan A; Kong D; Wang Z; Zhao Y
    Int J Pharm; 2015 Nov; 495(1):572-578. PubMed ID: 26387617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.
    Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G
    Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells.
    Nosrati H; Adibtabar M; Sharafi A; Danafar H; Hamidreza Kheiri M
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1377-1384. PubMed ID: 29560737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functionalized docetaxel-loaded lipid-based-nanosuspensions to enhance antitumor efficacy in vivo.
    Pang X; Wang T; Jiang D; Mu W; Zhang B; Zhang N
    Int J Nanomedicine; 2019; 14():2543-2555. PubMed ID: 31114190
    [No Abstract]   [Full Text] [Related]  

  • 36. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
    Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
    J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
    Yang Z; Sun N; Cheng R; Zhao C; Liu Z; Li X; Liu J; Tian Z
    Biomaterials; 2017 Dec; 147():53-67. PubMed ID: 28930649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation.
    Dong X; Zou S; Guo C; Wang K; Zhao F; Fan H; Yin J; Chen D
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):168-177. PubMed ID: 29239219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and cytotoxicity of folate-modified curcumin-loaded PLA-PEG micellar nano systems with various PLA:PEG ratios.
    Phan QT; Le MH; Le TT; Tran TH; Xuan PN; Ha PT
    Int J Pharm; 2016 Jun; 507(1-2):32-40. PubMed ID: 27150945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells.
    Xu S; Cui F; Huang D; Zhang D; Zhu A; Sun X; Cao Y; Ding S; Wang Y; Gao E; Zhang F
    Int J Nanomedicine; 2019; 14():17-32. PubMed ID: 30587982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.